Last reviewed · How we verify
NCT01522092
Escitalopram in Anxiety Associated Chronic Obstructive Pulmonary Disease (COPD) Exacerbations
Phase 3 trial testing escitalopram in Anxiety. Withdrawn.
Quick facts
| Lead sponsor | Hull University Teaching Hospitals NHS Trust |
|---|---|
| Phase | Phase 3 |
| Status | Withdrawn |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | treatment |
| Sites | 1 location across United Kingdom |
Drugs / interventions tested
- escitalopram (escitalopram) — full drug profile →
Conditions studied
Sponsor
Hull University Teaching Hospitals NHS Trust
Who can join
Adults 40 to 80, any sex, with Anxiety or COPD. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Anxiety and depression are common in patients with severe chronic obstructive pulmonary disease (COPD). Frequently exacerbation's of breathlessness are associated with panic/fear and indeed this may be the main cause for the for hospital admission. Patients prone to a tendency to experience and communicate somatic distress in response to psychosocial stress and to seek medical help for it are top of the "frequent flyer" league, costing the health care economy dearly. This is a particular problem in Hull with the high levels of smoking and urban deprivation combining to place the city at the bottom of the Department of Health COPD league tables. Our hypothesis is that an effective treatment for anxiety will reduce the number of episodes of hospital admission by reducing the panic/fear element of mild COPD exacerbation's thus allowing the patient time to access the existing community based support services.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT01522092
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of escitalopram
Trials testing the same drug.
- NCT05866575 — Prediction of the Therapeutic Response in Depression Based on Neuro-computational Modeling Assessment of Motivation · NA · recruiting
- NCT03899194 — Study on the Effect of PRKCB1 Modulating Inflammatory Factors and the Role for Developing Major Depressive Disorder · NA · unknown
- NCT03511118 — Pharmacokinetics and Safety of Commonly Used Drugs in Lactating Women and Breastfed Infants · recruiting
- NCT03010761 — Establishment of Cessation Therapy by Clinical Trials for Subjects With Betel-quid Dependence and Oral Pre-cancer · Phase 2 · terminated
Other recruiting trials for Anxiety
Currently open trials in the same condition.
- NCT07336238 — Group Retreat Psilocybin Therapy for the Treatment of Anxiety and Depression in Patients With Metastatic Solid Tumors or · Phase 2 · recruiting
- NCT07522944 — AI-Guided Relaxation for Hemodialysis Anxiety · NA · recruiting
- NCT07466875 — Auricular Stimulation for Nicotine Withdrawal in Psychiatric Inpatients · NA · recruiting
- NCT07425951 — Building Cognitive Behavioural Skills With StoryBooks to Reduce Emotional Difficulties in Kindergarten Years · NA · recruiting
- NCT07473505 — Integrative Bilateral Cervical Sympathetic Blocks for Trauma-Related Symptoms in Special Operations Veterans: A Prospect · recruiting
Other Hull University Teaching Hospitals NHS Trust trials
Trials by the same sponsor.
- NCT07502040 — Impact of Exercise Access on Physio Outcomes Post Knee Replacement · NA · not yet recruiting
- NCT07483502 — The Effects of a 6-week Pre-operative Administration of a Microbiome Modulator "WellBiome" Versus Placebo on Cardiac Sur · NA · not yet recruiting
- NCT07427550 — Palliative Care and The Terminally Ill Adults (End of Life) Bill · not yet recruiting
- NCT06876506 — Identification of B Regulatory Cells by Flow Cytometry · not yet recruiting
- NCT07409519 — Nutritional Screening in Cardiovascular Disease · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT01522092 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Hull University Teaching Hospitals NHS Trust
- Last refreshed: 29 March 2017
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT01522092.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing